Molecular Cancer
Scope & Guideline
Unlocking the secrets of cancer biology and treatment.
Introduction
Aims and Scopes
- Molecular Mechanisms of Cancer:
The journal explores the intricate molecular pathways that contribute to cancer development, progression, and metastasis, including genetic mutations, epigenetic modifications, and signaling pathways. - Cancer Immunology and Immunotherapy:
A significant focus is on the immune system's role in cancer, including the mechanisms of immune evasion by tumors and the development of innovative immunotherapeutic strategies. - Non-coding RNAs and Circular RNAs:
Research on non-coding RNAs, particularly circular RNAs, is a core area, examining their roles in gene regulation, tumor progression, and potential as therapeutic targets. - Tumor Microenvironment and Metabolism:
The journal investigates the relationship between tumor cells and their microenvironment, including the metabolic reprogramming of cancer cells and the influence of stromal components on tumor behavior. - Liquid Biopsy and Biomarkers:
There is a strong emphasis on the development and validation of biomarkers for cancer diagnosis, prognosis, and treatment response, particularly through liquid biopsy technologies. - Targeted and Personalized Therapies:
Research on targeted therapies, including small molecules and biologics, is prevalent, focusing on identifying actionable mutations and developing personalized treatment approaches. - Translational and Clinical Research:
The journal aims to bridge basic research with clinical applications, promoting studies that translate laboratory findings into therapeutic strategies for cancer patients.
Trending and Emerging
- Circular RNAs and Their Therapeutic Potential:
Research on circular RNAs has surged, exploring their mechanisms in cancer biology and their potential as therapeutic targets and biomarkers. - Multi-Omics Approaches:
There is a growing trend towards integrating multi-omics analyses (genomics, transcriptomics, proteomics) to better understand cancer heterogeneity and inform personalized therapies. - Cancer Immunometabolism:
The intersection of cancer metabolism and immunology is gaining traction, with studies focusing on how metabolic pathways influence immune responses in the tumor microenvironment. - CRISPR and Gene Editing Technologies:
The application of CRISPR and other gene editing technologies in cancer research is rapidly expanding, focusing on their potential to create novel therapies and understand gene function in cancer. - Liquid Biopsy Innovations:
Innovative approaches to liquid biopsy are emerging, with research targeting circulating tumor DNA and exosomal RNA as non-invasive methods for cancer detection and monitoring. - Targeting the Tumor Microenvironment:
There is an increasing emphasis on understanding and targeting the tumor microenvironment, particularly the roles of cancer-associated fibroblasts and immune cells in tumor progression and therapy resistance. - Combination Therapies and Personalized Medicine:
Research is increasingly focused on combination therapies that leverage advances in genomics and immunotherapy, aiming for personalized treatment strategies that improve patient outcomes.
Declining or Waning
- Traditional Chemotherapy Mechanisms:
There has been a noticeable decrease in publications focusing solely on traditional chemotherapy mechanisms, as the field shifts towards exploring combination therapies and personalized approaches. - Basic Cancer Genetics without Functional Insights:
Research that merely catalogs genetic mutations in cancers without functional validation or therapeutic implications is less frequently seen, as the emphasis has shifted to understanding the functional consequences of these mutations. - In vitro Studies with Limited Clinical Relevance:
Studies that focus solely on in vitro models without robust links to clinical outcomes or translational potential are becoming less prevalent, as researchers prioritize more clinically relevant models. - Single-Target Therapies:
Interest in single-target therapies has waned, with a growing focus on combination therapies and multi-target strategies that address the complexity of cancer biology. - Historical Cancer Treatments:
Research centered on older treatment modalities without novel insights or improvements has decreased, as the field moves towards innovative therapies and precision medicine.
Similar Journals
INTERNATIONAL JOURNAL OF CANCER
Empowering discoveries in oncology and cancer biology.INTERNATIONAL JOURNAL OF CANCER, published by Wiley, stands as a premier platform for the dissemination of cutting-edge research in the fields of cancer research and oncology. With an impressive impact factor reflecting its rigorous peer-review process and significant contribution to the scientific community, this journal is categorized in Q1 for both Cancer Research and Oncology as of 2023. It boasts notable rankings, being placed 38th among 404 journals in Medicine - Oncology and 32nd among 230 in Biochemistry, Genetics, and Molecular Biology - Cancer Research, positioning it within the 90th and 86th percentiles, respectively. Since its inception in 1966 and continuing to 2024, the journal has played a pivotal role in advancing our understanding of cancer biology, treatment modalities, and innovative therapeutic approaches. While it operates under a subscription model, the journal is committed to making valuable research accessible to a broader scientific audience. Researchers, professionals, and students alike will find the INTERNATIONAL JOURNAL OF CANCER an essential resource for staying abreast of the latest advancements in cancer science.
CANCER AND METASTASIS REVIEWS
Pioneering Discoveries in Cancer and MetastasisCancer and Metastasis Reviews, published by Springer, is a leading journal in the field of oncology and cancer research. With an impressive impact factor placing it in the Q1 category for both Cancer Research and Oncology as of 2023, this journal is ranked 29th out of 404 in Medicine, Oncology, and 22nd out of 230 in Biochemistry, Genetics, and Molecular Biology, reflecting its significant influence and prestige in the academic community. Established in 1982, the journal covers a wide spectrum of topics related to the mechanisms of cancer progression and metastasis, making it an essential resource for researchers, healthcare professionals, and students dedicated to understanding and tackling cancer. Although the journal does not provide open access options, the impactful research it publishes contributes to advances in therapeutic strategies and enhances the collective knowledge surrounding cancer pathophysiology. With research converging from 1982 to 2024, Cancer and Metastasis Reviews continues to be a vital platform for disseminating high-quality scientific information in the ever-evolving landscape of cancer research.
INTERNATIONAL JOURNAL OF ONCOLOGY
Transforming discoveries into impactful cancer solutions.INTERNATIONAL JOURNAL OF ONCOLOGY is a leading academic publication dedicated to advancing the field of cancer research and treatment. Published by SPANDIDOS PUBL LTD in Greece, this journal, with ISSN 1019-6439 and E-ISSN 1791-2423, has established itself as a reputable source of peer-reviewed articles since its inception in 1993. With an impressive Q2 ranking in both Cancer Research and Oncology categories, as well as high Scopus ranks reflecting its significant contribution to the fields of Medicine and Biochemistry, the journal offers a platform for researchers, clinicians, and students alike to disseminate their findings and engage in dialogue surrounding innovative practices and breakthroughs. Although the journal follows a traditional subscription model, it continues to attract a diverse readership interested in the latest developments in oncological research, providing essential insights into cancer biology, therapeutics, and patient care. With a commitment to excellence, the INTERNATIONAL JOURNAL OF ONCOLOGY plays a vital role in shaping the future of oncology research and is a must-read for anyone passionate about advancing cancer treatment and prevention.
GENE THERAPY
Catalyzing Change in Genetic Disorder TreatmentsGENE THERAPY, published by SpringerNature, is a prestigious academic journal at the forefront of research in the fields of genetics, molecular biology, and molecular medicine. Since its inception in 1994, this journal has evolved into a vital resource for scholars, practitioners, and students, providing cutting-edge insights into gene therapy techniques and innovations. With an impressive impact factor reflecting its significant influence— ranking in the Q1 quartile across multiple categories in 2023—GENE THERAPY offers rigorous peer-reviewed articles that address both basic and applied aspects of gene therapy. The journal is recognized for its role in promoting advancements in therapeutic strategies, thus enhancing understanding of genetic disorders and treatment efficacy. Researchers will find this journal invaluable for publishing their findings, staying updated on the latest breakthroughs, and fostering interdisciplinary collaborations. Engage with the latest in gene therapy by accessing this influential platform, and contribute to a field that holds the potential to transform healthcare outcomes worldwide.
JOURNAL OF GENE MEDICINE
Empowering the Next Generation of Molecular MedicineThe Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.
Cancers
Advancing cancer research for a healthier tomorrow.Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.
Cancer Cell International
Transforming Knowledge into Cancer SolutionsCancer Cell International, published by BMC, is a transformative open-access journal established in 2001, dedicated to advancing the field of oncology and cancer research. With its ISSN number not specified and an E-ISSN of 1475-2867, the journal proudly operates from the United Kingdom, located at CAMPUS, 4 Crinan St, London N1 9XW, England. Renowned for its rigorous peer-review process, Cancer Cell International has made significant strides, securing a Q2 ranking in Cancer Research and Q1 rankings in both Genetics and Oncology as of 2023. It ranks impressively in Scopus, featuring in the top quintile of Genetics (#37/347) and Oncology (#52/404), indicating its importance within the scientific community. The journal's broad scope caters to a diverse array of topics within cancer biology, making it an invaluable resource for researchers, professionals, and students seeking to stay at the forefront of cancer science. With a commitment to disseminating high-quality research, Cancer Cell International invites scholars to explore innovative findings and contribute to the collective effort of combating cancer.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Unlocking the secrets of cancer biology and therapy.The JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, published by BMC, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. Since its inception in 1982, this esteemed journal has fostered innovation and collaboration in the scientific community, as evidenced by its outstanding impact factor and position in the Q1 quartile for both Cancer Research and Oncology categories in 2023. With a proud commitment to disseminating high-quality research, the journal operates under an open-access model, ensuring that findings are readily accessible to researchers, healthcare professionals, and students worldwide. The journal has established a distinguished reputation, ranking 23rd out of 404 in Medicine oncology and 16th out of 230 in Biochemistry, Genetics, and Molecular Biology (cancer research), showcasing its importance and influence in guiding the future of cancer treatment and research. With the aim of bridging experimental and clinical research, this journal invites submissions that push the boundaries of our understanding of cancer biology and therapy.
CANCER INVESTIGATION
Driving innovation in cancer studies for impactful discoveries.CANCER INVESTIGATION is a distinguished peer-reviewed journal published by Taylor & Francis Inc, dedicated to the advancing field of cancer research and oncology. With an ISSN of 0735-7907 and E-ISSN of 1532-4192, this journal has been a pivotal resource for professionals and researchers since its inception in 1983, continually contributing to the evolving landscape of cancer investigation until its convergence in 2024. CANCER INVESTIGATION boasts noteworthy rankings in 2023, including Q3 in Cancer Research and Q2 in Medicine (miscellaneous), highlighting its relevance and impact in these critical areas. The journal's commitment to disseminating innovative research and comprehensive reviews makes it an essential platform for those engaged in cancer studies and related disciplines. While currently not available as an open-access publication, CANCER INVESTIGATION remains an invaluable tool for understanding the complexities of cancer, offering insights that drive scientific advancements and improve patient outcomes.
ONCOLOGY RESEARCH
Fostering Excellence in Oncology Research and PracticeONCOLOGY RESEARCH, published by TECH SCIENCE PRESS, is a vital academic journal dedicated to the rapidly evolving field of oncology. With its ISSN 0965-0407 and E-ISSN 1555-3906, the journal serves as a key resource for researchers, clinicians, and academicians committed to advancing cancer research and treatment strategies. Operating without an Open Access model, ONCOLOGY RESEARCH provides high-quality, peer-reviewed articles that cover diverse topics within cancer research, medicine, and oncology, with its 2023 Scopus ranking placing it in the Q3 quartile. The journal's commitment to facilitating rigorous scientific discourse is evident in its historical breadth, with a publishing history dating back to 1992. ONCOLOGY RESEARCH is not only significant for the academic community but also plays a critical role in fostering new insights and approaches in the fight against cancer, making it a must-read for those involved in this critical area of study.